Veterinary Medicines

Vanguard Plus 5 vakcina A.U.V.

Authorised
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain N-CDV, Live
Download as PDF

Product identification

Medicine name:
Vanguard Plus 5 vakcina A.U.V.
Active substance:
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain N-CDV, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain NL-35-D, Live
    7.00
    log10 cell culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    6.00
    log10 cell culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine adenovirus 2, strain Manhattan, Live
    3.20
    log10 cell culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Canine distemper virus, strain N-CDV, Live
    3.00
    log10 cell culture infective dose 50
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."